EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C17H23N3O3S2 |
| Net Charge | 0 |
| Average Mass | 381.523 |
| Monoisotopic Mass | 381.11808 |
| SMILES | CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCOCC3)s2)o1 |
| InChI | InChI=1S/C17H23N3O3S2/c1-17(2,3)12-8-18-13(23-12)10-24-14-9-19-16(25-14)20-15(21)11-4-6-22-7-5-11/h8-9,11H,4-7,10H2,1-3H3,(H,19,20,21) |
| InChIKey | VCSNYLCSFYGQIN-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | EC 2.7.11.22 (cyclin-dependent kinase) inhibitor An EC 2.7.11.* (protein-serine/threonine kinase) inhibitor that interferes with the action of cyclin-dependent kinase (EC 2.7.11.22). |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) has role EC 2.7.11.22 (cyclin-dependent kinase) inhibitor (CHEBI:82665) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) is a 1,3-oxazoles (CHEBI:46812) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) is a 1,3-thiazoles (CHEBI:38418) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) is a organic sulfide (CHEBI:16385) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) is a oxanes (CHEBI:46942) |
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide (CHEBI:143113) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)tetrahydro-2H-pyran-4-carboxamide |
| Synonym | Source |
|---|---|
| UNC-CAF-143 | ChEBI |